ARIR: Antibiotice, Impetum Group, MedLife first to hire COR-compliant Investor Relations Specialists in Romania

Miruna Macsim 17/01/2024 | 16:46

ARIR (Romanian Investor Relations Association), the promoter of the Investor Relations (IR) concept, announces the first companies that have hired Specialists and Directors in Investor Relations (IR) using the new positions from the Classification of Occupations in Romania (COR), operational since 2023. These companies are Antibiotice, Impetum Group, and MedLife.

 

Starting from August 2023, Antibiotice has filled two positions for “Specialist in Investor Relations,” bringingCarmen Elena Diaconu and Bogdan Andrei Ghiarasim in these roles. Both are recognized as professionals in the field and contribute to strengthening the company’s position in the pharmaceutical industry, as well as in terms of the quality of communication with investors.

“ARIR considers that by adhering to standards of transparency, corporate governance, and proactivity in the communication with investors, companies will benefit from added value, attract financing more easily, and gain the reputation and the trust necessary for the continuous development of their businesses. In collaboration with the capital market institutions, we contributed to the inclusion of Specialists and Directors in IR occupations in theClassification of Occupations in Romania. Thus, employees specialized in investor relations have received formal recognition of their role, and listed companies can increase their visibility by recruiting these specialists.” says Daniela Maior (Șerban), ARIR President, MP VERTIK Group.

Starting from October 2023, Ana-Maria Imbrea has taken the role of Head of Investor Relations at Impetum Group, bringing to the team a solid experience in investor relations, finance, sustainability, communication, and audit, gained throughout her professional career. The Impetum team also includes Alexandra Țițan, a professional with extensive experience in investor relations. She is the Head of Investor Relations for the group’s companies, Roca Industry (BVB symbol: ROC1) and Roca Investments (private equity).

Since November 2023, MedLife has recruited Ioana Bîrsu as the Haed of Investor Relations, a professional in financial services with experience in the field of investor relations.

“The official recognition of these two occupations in the field of IR in Romania represents not only a step forward for the development of the capital market, but also a confirmation of the added value that investor relations bring to companies that adopt the best practices in corporate governance and transparency in their operations. At Impetum Group, we aim to align with international standards in terms of specialized communication with investors, and therefore, the recruitment of experts in the field is a key element and a confirmation for our investors that we are focused on excellence in all aspects of our activity.” adds Ana-Maria Imbrea, Head of Investor Relations, Impetum Group.

Through the initiative of ARIR, with the support of KPMG Legal – Toncescu și Asociații SPRL, backed by the Financial Supervisory Authority and the Bucharest Stock Exchange, two new codes have been introduced in the Classification of Occupations in Romania (COR), for the positions of Director of Investor Relations (COR 121920) and Specialist in Investor Relations (COR 241272). These codes became usable, including in the Revisal platform, starting from April 10, 2023. ARIR estimates an increase in the number of people being trained in this field, as well as increased attention from companies in recruiting specialized personnel, thereby strengthening the development of the capital market.

BR Magazine | Latest Issue

Download PDF: Business Review Magazine April 2024 Issue

The April 2024 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Caring for People and for the Planet”. To download the magazine in
Miruna Macsim | 12/04/2024 | 17:28
Advertisement Advertisement
Close ×

We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

Accept & continue